Van Cutsem, E <br/><br/>
Optimisation of irinotecan dose in the treatment of patients with metastatic colorectal cancer after 5-FU failure: results from a multinational, randomised phase II study.  [electronic resource] 

 -  British journal of cancer  Mar 2005 
 - 1055-62 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0007-0920 
<br/><br/><label>Standard No.: </label>10.1038/sj.bjc.6602462  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Camptothecin--administration & dosage<br/>Colorectal Neoplasms--drug therapy<br/>Female<br/>Fluorouracil--therapeutic use<br/>Humans<br/>Irinotecan<br/>Male<br/>Middle Aged<br/>Neoplasm Metastasis<br/>Treatment Failure